Sofinnova Capital IX
- SEC CIK
- 0001849915
No open-market purchases or sales filed in the past year.
Current role at each company
- CINC CinCor Pharma, Inc.10% Owneras of Aug 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sofinnova Capital IX as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 (view filing)4:19 PM ET | Aug 15 | 2 days | Sofinnova Partners SAS and 1 other10% Owner | PPurchase | +133.3K | $30.00 | +$4.00M | +3.3%4.22M after | |
| Jan 13, 2022 (view filing)4:36 PM ET | Jan 11 | 2 days | Sofinnova Partners SAS and 1 other10% Owner | PPurchase | +220.0K | $16.00 | +$3.52M | +5.7%4.09M after |